糖足治疗

Search documents
2025年中国糖足治疗行发展历程、产业链图谱、市场规模、竞争格局及发展趋势研判:糖足患者人数持续增加,市场需求持续增长[图]
Chan Ye Xin Xi Wang· 2025-07-24 01:40
Overview - The diabetic foot treatment market in China is projected to reach CNY 214.14 billion in 2024, with a year-on-year growth of 3.67%. Medical services account for 82.4% of the market, while diabetic foot medications make up 17.6% [1][8] - The largest share of the diabetic foot medication market is held by chemical drugs at 9.0%, followed by wound dressings at 5.6% and biological products at 2.1% [1][8] - The increasing awareness of diabetes foot and the aging population are expected to further expand the market demand for diabetic foot treatment [1][8] Development History - Research on diabetic foot treatment in China began in the 1990s, with significant advancements in clinical diagnosis and treatment standards [4] - The introduction of multidisciplinary treatment models has improved diabetic foot management, and new technologies such as spinal cord stimulators have emerged as treatment options [4] Background - China has a significant number of diabetes patients, with 148 million diagnosed and an additional 274 million in the pre-diabetic stage. The diabetic foot is a severe complication affecting these patients [6] - The number of diabetic foot patients in China is expected to reach 8.3 million in 2024, reflecting a year-on-year increase of 2.47% [6] Current Market Status - The diabetic foot treatment market is expanding due to the large patient population, with a market size of CNY 214.14 billion projected for 2024 [8] - The demand for diabetic foot treatment is expected to grow as health knowledge improves and more patients seek timely medical care [8] Competitive Landscape - The diabetic foot treatment industry in China features a competitive landscape with both multinational and domestic companies. Multinational firms dominate the high-end market, while domestic companies focus on generic drugs and innovative drug development [10] - Key players in the market include companies like Innovent Biologics, East China Pharmaceutical, and Hengrui Medicine, which are involved in various segments of diabetic foot treatment [10][12][14] Future Trends - The future of diabetic foot treatment will see a more mature multidisciplinary collaboration model, enhancing treatment effectiveness and reducing amputation rates [16] - Increased focus on prevention and education for patients and their families is expected, along with regular screening for high-risk populations to mitigate the incidence and severity of diabetic foot [16]